- Home
- / Genexine
Genexine
Stock Price
₩10 K
2023-11-20
Market Capitalization
₩203.5 B
2023-11-20
Revenue
₩16.1 B
FY, 2022
Genexine Summary
Company Summary
- Overview
- Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics. It builds the hyFc technology, a proprietary platform designed to drive the discovery of differentiated protein therapeutics.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Seongnam-si, KR | view all locations
- Website
- http://www.genexine.com
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
2 locations detected
Seongnam-si, Gyeonggi-do HQ
Korea (Republic of)
New York, NY
United States
Lefcourt Colonial Building, 295 Madison Ave #1201
Genexine Financials
Summary Financials
- Revenue (Q2, 2023)
- ₩1.8B
- Gross profit (Q2, 2023)
- ₩1.8B
- Net income (Q2, 2023)
- (₩24.6B)
- Cash (Q2, 2023)
- ₩59.5B
- EBIT (Q2, 2023)
- (₩24.7B)
- Enterprise value
- $218.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2023